虽然抗血管内皮生长因子治疗不能治愈Coats病，但是经玻璃体腔注药后，

Although anti-vascular endothelial growth factor therapy cannot cure Coats disease, the subretinal fluid will be significantly absorbed after the drug is injected into the vitreous cavity. In this study, 4 patients (28.57%) underwent subretinal fluid drainage once. Because the subretinal fluid drainage is time-sensitive, in order to prevent recurrence of exudative retinal detachment, multiple intravitreal injections of drugs were required. Promote the absorption of subretinal fluid and reduce blood vessel leakage. During the follow-up, patients who had no subretinal fluid or exudation after intravitreal injection of anti-VEGF.

Although the treatment of antivascular endothelial growth factor cannot cure Coats disease, the lower retinal fluid is significantly absorbed after being injected with a glass cavity. In this study, 4 patients (28.57%) carried out 1 sub-retinal fluid drainage, because of the timeliness of the sub-retinal fluid drainage surgery, so in order to prevent the recurrence of oozing retinal separation, to multiple glass cavity injection drugs, promote the absorption of lower retinal fluid, reduce blood vessel leakage. In follow-up, patients who did not see subresinal fluid or oozing after being injected with anti-VEGF through the glass body.

Although anti vascular endothelial growth factor therapy cannot cure Coats disease, subretinal fluid will be absorbed after intravitreal injection. In order to reduce the subretinal fluid leakage, the subretinal fluid was injected into the subretinal fluid for 4 times. During the follow-up period, no subretinal fluid or exudation was found after intravitreal injection of anti VEGF.<br>